302 related articles for article (PubMed ID: 21129028)
1. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
Sharma P; Agrawal A; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2011 Jun; 26(6):996-1003. PubMed ID: 21129028
[TBL] [Abstract][Full Text] [Related]
2. Lactulose a day keeps encephalopathy at bay.
Klinken E; MacQuillan G
J Gastroenterol Hepatol; 2011 Jun; 26(6):939-40. PubMed ID: 21564285
[No Abstract] [Full Text] [Related]
3. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
4. Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding.
Higuera-de-la-Tijera F; Servín-Caamaño AI; Salas-Gordillo F; Pérez-Hernández JL; Abdo-Francis JM; Camacho-Aguilera J; Alla SN; Jiménez-Ponce F
Can J Gastroenterol Hepatol; 2018; 2018():3015891. PubMed ID: 30079329
[TBL] [Abstract][Full Text] [Related]
5. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
6. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding.
Aires FT; Ramos PT; Bernardo WM
Rev Assoc Med Bras (1992); 2016; 62(3):243-7. PubMed ID: 27310548
[TBL] [Abstract][Full Text] [Related]
8. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Wen J; Liu Q; Song J; Tong M; Peng L; Liang H
Digestion; 2013; 87(2):132-8. PubMed ID: 23485720
[TBL] [Abstract][Full Text] [Related]
9. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
[TBL] [Abstract][Full Text] [Related]
10. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
[TBL] [Abstract][Full Text] [Related]
11. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
12. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
13. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
[TBL] [Abstract][Full Text] [Related]
14. Higher free serum cortisol is associated with worse survival in acute variceal bleeding because of cirrhosis: a prospective study.
Triantos CK; Kalafateli M; Samonakis D; Zisimopoulos K; Papiamonis N; Sapountzis A; Michalaki M; Theocharis G; Thomopoulos K; Labropoulou-Karatza C; Kyriazopoulou V; Jelastopulu E; Kouroumalis EA; Nikolopoulou V; Burroughs AK
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1125-32. PubMed ID: 25089543
[TBL] [Abstract][Full Text] [Related]
15. Acute Variceal Bleeding: Does Octreotide Improve Outcomes in Patients with Different Functional Hepatic Reserve?
Monreal-Robles R; Cortez-Hernández CA; González-González JA; Abraldes JG; Bosques-Padilla FJ; Silva-Ramos HN; García-Flores JA; Maldonado-Garza HJ
Ann Hepatol; 2018; 17(1):125-133. PubMed ID: 29311398
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
Irimia R; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
[TBL] [Abstract][Full Text] [Related]
17. [Coexistence of various diseases and the analysis of the causes of death in patients with liver cirrhosis].
Marlicz K; Szymański Z; Wierzbicka-Paczos E; Tarnowska M; Kordowska M; Kotańska K
Przegl Lek; 1984; 41(10):617-20. PubMed ID: 6336252
[No Abstract] [Full Text] [Related]
18. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
[TBL] [Abstract][Full Text] [Related]
19. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
Abid S; Jafri W; Hamid S; Salih M; Azam Z; Mumtaz K; Shah HA; Abbas Z
Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
[TBL] [Abstract][Full Text] [Related]
20. Update on management of patients with overt hepatic encephalopathy.
Chacko KR; Sigal SH
Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]